Mohammad Tadayyon
27Patents
21h-index
19Co-inventors
78Inventor score
Filing activity: Dec 18, 2001 → Mar 15, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7407955B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 120 | Expired |
| US7495002B2 | 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions | Human Necessities | 120 | Active |
| US7217711B2 | Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions | Human Necessities | 101 | Expired |
| US8178541B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 96 | Active |
| US7109192B2 | Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 93 | Expired |
| US7179809B2 | 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions | Chemistry; Metallurgy | 84 | Expired |
| US7183280B2 | Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 84 | Expired |
| US7501426B2 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | Human Necessities | 84 | Expired |
| US7482337B2 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Human Necessities | 79 | Expired |
| US7550455B2 | 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition | Chemistry; Metallurgy | 79 | Expired |
| US7645763B2 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition | Human Necessities | 77 | Active |
| US7495003B2 | 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 64 | Active |
| US7470716B2 | Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions | Chemistry; Metallurgy | 64 | Active |
| US7393847B2 | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions | Chemistry; Metallurgy | 64 | Expired |
| US7560450B2 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 63 | Expired |
| US7476671B2 | 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions | Chemistry; Metallurgy | 63 | Active |
| US7566707B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 63 | Expired |
| US7432262B2 | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions | Chemistry; Metallurgy | 63 | Active |
| US8664232B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 43 | Active |
| US8697868B2 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | Human Necessities | 28 | Active |
| US9321791B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 27 | Active |
| US7696212B2 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Human Necessities | 11 | Active |
| US7220777B2 | Lactam derivatives as antagonists for human 11cby receptors | Chemistry; Metallurgy | 9 | Expired |
| US7241579B2 | Method of screening for GPR40 ligands | Chemistry; Metallurgy | 1 | Expired |
| US7906539B2 | Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.